AGEN ▲ +0.1% - Agenus Inc. $AGEN Agenus Announces Nature Medicine Publication of Multicenter UNICORN Phase 2 Trial Demonstrating Deep Responses with Neoadjuvant BOT+BAL in Resectable Colon Cancer 02-NOV-2026 06:46 AM ET